Scotia Capital’s Lam Research LRCX Stock Holding History

Scotia Capital’s Portfolio LRCX Stock Details LRCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-100,000	Closed	-$794K	–	787
2015 Q4	$794K	Hold	100,000	–	–	0.02%	459
2015 Q3	$653K	Buy	+100,000	New	+$733K	0.01%	484

Other funds holding LRCX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Scotia Capital's LRCX Position: Q1 2026 in Review

Scotia Capital increased its Lam Research (LRCX) stake by 498% in Q1 2026, buying an estimated $55.9M and bringing the position to 300,456 shares worth $64.2M. The position accounts for 0.26% of the portfolio, ranked #65.

Scotia Capital first reported a position in LRCX in Q3 2014 and has held it in 39 quarters since. 2,630 funds tracked by Wall St. Rank hold LRCX as of Q1 2026.

Scotia Capital held 300,456 shares of Lam Research worth $64.2M as of Q1 2026.
Scotia Capital bought 250,202 Lam Research shares in Q1 2026, an estimated $55.9M.
Lam Research made up 0.26% of Scotia Capital's portfolio in Q1 2026, its #65 holding.
Scotia Capital first reported a position in Lam Research in Q3 2014 and has held it in 39 quarters since.
2,630 funds tracked by Wall St. Rank held Lam Research as of Q1 2026.

Based on Scotia Capital's 13F filing for Q1 2026, filed 13 May 2026.